PL2173196T3 - Zastosowanie probiotyków i włókien w biegunce - Google Patents

Zastosowanie probiotyków i włókien w biegunce

Info

Publication number
PL2173196T3
PL2173196T3 PL08766875T PL08766875T PL2173196T3 PL 2173196 T3 PL2173196 T3 PL 2173196T3 PL 08766875 T PL08766875 T PL 08766875T PL 08766875 T PL08766875 T PL 08766875T PL 2173196 T3 PL2173196 T3 PL 2173196T3
Authority
PL
Poland
Prior art keywords
diarrhoea
probiotics
fibers
inulin
treatment
Prior art date
Application number
PL08766875T
Other languages
English (en)
Inventor
Jacques Bindels
Anna Christina Goedhart
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38522548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2173196(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2173196T3 publication Critical patent/PL2173196T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
PL08766875T 2007-07-06 2008-07-04 Zastosowanie probiotyków i włókien w biegunce PL2173196T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07111951 2007-07-06
EP08766875A EP2173196B1 (en) 2007-07-06 2008-07-04 Use of probiotics and fibers for diarrhoea
PCT/NL2008/050454 WO2009008717A1 (en) 2007-07-06 2008-07-04 Use of probiotics and fibers for diarrhoea

Publications (1)

Publication Number Publication Date
PL2173196T3 true PL2173196T3 (pl) 2011-06-30

Family

ID=38522548

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08766875T PL2173196T3 (pl) 2007-07-06 2008-07-04 Zastosowanie probiotyków i włókien w biegunce

Country Status (10)

Country Link
US (1) US20110014167A1 (pl)
EP (1) EP2173196B1 (pl)
CN (1) CN101772308B (pl)
AT (1) ATE498325T1 (pl)
DE (1) DE602008005025D1 (pl)
ES (1) ES2360573T3 (pl)
PL (1) PL2173196T3 (pl)
PT (1) PT2173196E (pl)
RU (1) RU2469558C2 (pl)
WO (1) WO2009008717A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2014062683A1 (en) 2012-10-15 2014-04-24 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
WO2015159125A1 (en) * 2014-04-15 2015-10-22 Compagnie Gervais Danone Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
RU2767400C2 (ru) * 2018-07-05 2022-03-17 Общество С Ограниченной Ответственностью "Валента - Интеллект" Пробиотическая композиция для восстановления и поддержания сбалансированной микрофлоры кишечника у детей и младенцев и способ ее получения
JP7396798B2 (ja) * 2019-02-22 2023-12-12 帝人株式会社 腸内酪酸産生促進用組成物
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
WO2022269539A1 (en) * 2021-06-23 2022-12-29 Danstar Ferment Ag Method for favoring wellness and facilitating self-control before, during and/or after a restrictive diet

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
PL1675481T3 (pl) * 2003-10-24 2009-03-31 Nutricia Nv Kompozycja synbiotyczna dla niemowląt
WO2006046871A2 (en) * 2004-10-29 2006-05-04 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus
EP2805625B2 (en) * 2005-02-28 2022-11-23 N.V. Nutricia Nutritional composition with prebiotics and probiotics
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
EP1714660A1 (en) * 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
CA2580591A1 (en) * 2006-03-03 2007-09-03 Health Beverage, Llc Fiber containing alkaline beverage and methods for production thereof

Also Published As

Publication number Publication date
PT2173196E (pt) 2011-05-23
RU2469558C2 (ru) 2012-12-20
DE602008005025D1 (de) 2011-03-31
ATE498325T1 (de) 2011-03-15
CN101772308A (zh) 2010-07-07
WO2009008717A1 (en) 2009-01-15
CN101772308B (zh) 2013-08-28
RU2010104008A (ru) 2011-08-20
ES2360573T3 (es) 2011-06-07
EP2173196B1 (en) 2011-02-16
EP2173196A1 (en) 2010-04-14
US20110014167A1 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
PL2173196T3 (pl) Zastosowanie probiotyków i włókien w biegunce
IN2012DN01638A (pl)
MX2012005524A (es) Cepa de probioticos bifidobacterium.
MX337838B (es) Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias.
BRPI1010637A2 (pt) suplementos nutricionais orais compreendendo probióticos
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
MY156849A (en) Novel lactobacillus plantarum and composition comprising the same
IL200407A0 (en) Stable digestive enzyme compositions, methods of producing the same and uses thereof
EP2405918A4 (en) PREBIOTIC OLIGOSACCHARIDE
PL2134833T3 (pl) Probiotyczny szczep Bifidobacterium
PH12013502192A1 (en) Antibodies against human angiopoietin 2
UA100551C2 (en) Synbiotic mixture
WO2008053444A3 (en) Treating a respiratory condition with bifidobacterium
WO2009130423A3 (fr) Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices
MY146595A (en) Probiotic bifidobacterium strains
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MX2010007867A (es) Composiciones de limpieza personal concentradas.
WO2009156405A8 (en) Novel immunoadjuvant flagellin-based compounds and use thereof
ZA200908063B (en) Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
MY158310A (en) Prevention and treatment of allergic diarrhoea
GB2482817A (en) Novel use
TN2013000249A1 (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
JO2662B1 (en) Use of 4-methoxy-cyclopropyl-5, 3-N-dichloro-1-oxoperidine-4-yl-5 (methoxy) pyridine-2-carboxamide in the treatment of spinal cord injuries
TH102456B (th) การใช้พรีไบโอติค และเส้นใยสำหรับอาการท้องเสีย
MX2010007695A (es) Medios resistentes a abrasion.